Literature DB >> 26525489

Recent Developments in Neuropathic Pain Mechanisms: Implications for Treatment.

Wahida Rahman1, Anthony H Dickenson1.   

Abstract

Neuropathic pain is defined as "pain arising as a direct consequence of a lesion or disease affecting the somatosensory system".Characteristic symptoms include an increased evoked pain response to noxious (hyperalgesia) and innocuous (allodynia) stimuli, spontaneous pain, shooting electric shock like pain. Sensory deficits can also exist.Available treatments are not adequate in many patients due to many factors including the complexity of the pain state, disease progression, intolerable side effects and low analgesic efficacy.A number of peripheral, spinal and supraspinal mechanisms of hyperexcitability underlie neuropathic pain, these include changes in the activity and expression of voltage gated sodium, calcium and potassium channels, as well as TRPV1 channels and alterations in the activity of neuroimmue pathways.NeP patients often experience depression, anxiety, sleep disturbances etc. alongside their pain. These co-morbidites significantly reduce quality of life and as such are key treatment considerations..Improved understanding of NeP mechanisms is encouraging targeting of treatment to the mechanisms that produce painful symptoms as opposed to the etiology of disease.

Entities:  

Year:  2011        PMID: 26525489      PMCID: PMC4590067          DOI: 10.1177/204946371100500204

Source DB:  PubMed          Journal:  Rev Pain


  39 in total

1.  Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1.

Authors:  Michael Costigan; Inna Belfer; Robert S Griffin; Feng Dai; Lee B Barrett; Giovanni Coppola; Tianxia Wu; Carly Kiselycznyk; Minakshi Poddar; Yan Lu; Luda Diatchenko; Shad Smith; Enrique J Cobos; Dmitri Zaykin; Andrew Allchorne; Edith Gershon; Jessica Livneh; Pei-Hong Shen; Lone Nikolajsen; Jaro Karppinen; Minna Männikkö; Anthi Kelempisioti; David Goldman; William Maixner; Daniel H Geschwind; Mitchell B Max; Ze'ev Seltzer; Clifford J Woolf
Journal:  Brain       Date:  2010-08-18       Impact factor: 13.501

2.  Capsaicin 8% topical patch (Qutenza)--a review of the evidence.

Authors:  Virginia M Jones; Katrina A Moore; David M Peterson
Journal:  J Pain Palliat Care Pharmacother       Date:  2011

3.  Spinal-supraspinal serotonergic circuits regulating neuropathic pain and its treatment with gabapentin.

Authors:  Rie Suzuki; Wahida Rahman; Lars J Rygh; Mark Webber; Stephen P Hunt; Anthony H Dickenson
Journal:  Pain       Date:  2005-10       Impact factor: 6.961

Review 4.  Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission.

Authors:  David J Dooley; Charles P Taylor; Sean Donevan; Douglas Feltner
Journal:  Trends Pharmacol Sci       Date:  2007-01-10       Impact factor: 14.819

5.  Peripheral nerve injury-induced changes in spinal alpha(2)-adrenoceptor-mediated modulation of mechanically evoked dorsal horn neuronal responses.

Authors:  Wahida Rahman; Richard D'Mello; Anthony H Dickenson
Journal:  J Pain       Date:  2008-01-28       Impact factor: 5.820

6.  Effects of a new potent analog of tocainide on hNav1.7 sodium channels and in vivo neuropathic pain models.

Authors:  C Ghelardini; J-F Desaphy; M Muraglia; F Corbo; R Matucci; A Dipalma; C Bertucci; M Pistolozzi; M Nesi; M Norcini; C Franchini; D Conte Camerino
Journal:  Neuroscience       Date:  2010-05-16       Impact factor: 3.590

Review 7.  Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.

Authors:  Ralf Baron; Andreas Binder; Gunnar Wasner
Journal:  Lancet Neurol       Date:  2010-08       Impact factor: 44.182

Review 8.  Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.

Authors:  Robert H Dworkin; Alec B O'Connor; Joseph Audette; Ralf Baron; Geoffrey K Gourlay; Maija L Haanpää; Joel L Kent; Elliot J Krane; Alyssa A Lebel; Robert M Levy; Sean C Mackey; John Mayer; Christine Miaskowski; Srinivasa N Raja; Andrew S C Rice; Kenneth E Schmader; Brett Stacey; Steven Stanos; Rolf-Detlef Treede; Dennis C Turk; Gary A Walco; Christopher D Wells
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

9.  Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain.

Authors:  Scott B Hoyt; Clare London; David Gorin; Matthew J Wyvratt; Michael H Fisher; Catherine Abbadie; John P Felix; Maria L Garcia; Xiaohua Li; Kathryn A Lyons; Erin McGowan; D Euan MacIntyre; William J Martin; Birgit T Priest; Amy Ritter; McHardy M Smith; Vivien A Warren; Brande S Williams; Gregory J Kaczorowski; William H Parsons
Journal:  Bioorg Med Chem Lett       Date:  2007-05-27       Impact factor: 2.823

Review 10.  The impact of neuropathic pain on health-related quality of life: review and implications.

Authors:  Mark P Jensen; Marci J Chodroff; Robert H Dworkin
Journal:  Neurology       Date:  2007-04-10       Impact factor: 9.910

View more
  3 in total

Review 1.  Spinal α2 -adrenoceptors and neuropathic pain modulation; therapeutic target.

Authors:  Zahra Bahari; Gholam Hossein Meftahi
Journal:  Br J Pharmacol       Date:  2019-03-06       Impact factor: 8.739

2.  Activation of the Locus Coeruleus Mediated by Designer Receptor Exclusively Activated by Designer Drug Restores Descending Nociceptive Inhibition after Traumatic Brain Injury in Rats.

Authors:  Karen-Amanda Irvine; Christopher M Peters; Elena M Vazey; Adam R Ferguson; J David Clark
Journal:  J Neurotrauma       Date:  2022-07       Impact factor: 4.869

3.  Monoamine control of descending pain modulation after mild traumatic brain injury.

Authors:  Peyman Sahbaie; Karen-Amanda Irvine; Xiao-You Shi; J David Clark
Journal:  Sci Rep       Date:  2022-09-29       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.